Viewing StudyNCT02899091



Ignite Creation Date: 2024-05-06 @ 9:04 AM
Last Modification Date: 2024-10-26 @ 12:09 PM
Study NCT ID: NCT02899091
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-09
First Post: 2016-09-02

Brief Title: Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimers Disease
Sponsor:
Organization: CHABiotech CO Ltd

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 24
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: